| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $366.4M | +33.9% |
| Cost of Revenue | $91.8M | +20.8% |
| Gross Profit | $274.6M | +38.9% |
| R&D Expense | $34.9M | +1.4% |
| SG&A Expense | $45.8M | +13.7% |
| Operating Income | -$26.1M | +59.9% |
| Pre-tax Income | -$8.7M | +86.0% |
| Income Tax | -$2.7M | -1.5% |
| Net Income | -$6.1M | +89.8% |
| EPS (Basic) | -$0.12 | +90.6% |
| EPS (Diluted) | -$0.12 | +90.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $104.8M | -56.1% |
| Short-term Investments | $240.1M | +102.9% |
| Accounts Receivable | $57.2M | +27.7% |
| Inventory | $79.9M | +43.4% |
| Current Assets | $491.4M | +5.7% |
| Total Assets | $719.9M | +9.2% |
| Current Liabilities | $45.8M | -29.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.0M | -163.2% |
| Capital Expenditures | $3.5M | +59.7% |
| Investing Cash Flow | -$116.9M | +2.9% |
| Financing Cash Flow | -$3.4M | -102.5% |
| Free Cash Flow | -$5.6M | -675.0% |
| Total Liabilities |
| $82.4M |
| -7.7% |
| Stockholders' Equity | $637.6M | +11.8% |